Tornier NV  

(Public, NASDAQ:TRNX)   Watch this stock  
Find more results for TRNX
-0.10 (-0.40%)
Jul 31 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 24.83 - 25.18
52 week 19.28 - 28.53
Open 25.08
Vol / Avg. 73,548.00/131,773.00
Mkt cap 1.22B
P/E     -
Div/yield     -
EPS -0.60
Shares 49.00M
Beta 1.27
Inst. own 97%
Aug 5, 2015
Q2 2015 Tornier NV Earnings Release - 4:00PM EDT - Add to calendar
Jun 18, 2015
Tornier NV Annual Shareholders Meeting
May 5, 2015
Q1 2015 Tornier NV Earnings Call
May 5, 2015
Q1 2015 Tornier NV Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '15) 2014
Net profit margin -5.81% -8.54%
Operating margin -4.18% -6.21%
EBITD margin - 6.86%
Return on average assets -3.15% -4.32%
Return on average equity -4.42% -5.87%
Employees 1,121 -
CDP Score - -


Prins Bernhardplein 200
+31-20-6754002 (Phone)
+31-10-4718888 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Tornier N.V. is a medical device company. The Company is focused on providing solutions to surgeons that treat musculoskeletal injuries and disorders of the shoulder, elbow, wrist, hand, ankle and foot, which is refer to as extremity joints. The Company sells to surgeons a line of joint replacement, trauma, sports medicine and biologic products to treat extremity joints. In certain international markets, it also offers joint replacement products for the hip and knee. The Company offers a product portfolio of over 90 extremities products that are designed to provide solutions to its surgeon customers. Its product portfolio consists product categories, which include upper extremity joints and trauma; lower extremity joints and trauma; sports medicine and biologics, and large joints and other. It has operations located in Bloomington, Minnesota, Grenoble, France, Macroom, Ireland, Warsaw, Indiana and Medina, Ohio. In addition, it conducts local sales and distribution activities.

Officers and directors

David H. Mowry President, Chief Executive Officer, Executive Director
Age: 51
Bio & Compensation  - Reuters
Shawn T McCormick Chief Financial Officer
Age: 49
Bio & Compensation  - Reuters
Kevin M Klemz Senior Vice President, chief legal officer, Secretary
Age: 53
Bio & Compensation  - Reuters
Stephan Epinette Senior Vice President-international commercial operations
Age: 43
Bio & Compensation  - Reuters
Gregory Morrison Senior Vice President-Global Human resources
Age: 50
Bio & Compensation  - Reuters
Terry M. Rich Senior Vice President - U.S. Commercial Operations
Age: 45
Bio & Compensation  - Reuters
Gordon W. Van Ummersen Senior Vice President of Global Product Delivery
Age: 53
Bio & Compensation  - Reuters
Sean D. Carney Non-Executive Independent Chairman of the Board
Age: 46
Bio & Compensation  - Reuters
Kevin C. O'Boyle CPA Interim Non-Executive Independent Vice Chairman of the Board
Age: 59
Bio & Compensation  - Reuters
Alain Tornier Non-Executive Director
Age: 68
Bio & Compensation  - Reuters